Infusion Therapy Services
If you need infusion therapy, the PACT Infusion Center is here to help. We offer flexible appointments in a comfortable setting.
Why Infusion Therapy?
Ideally medications are given by mouth and can be taken by patients at home but some medications need to be infused intravenously to treat certain conditions.
Infused medications affect the immune system in very targeted ways to reduce the inflammation caused by autoimmune conditions while largely preserving the body’s ability to combat infection
Infused medications are unable to be absorbed when taken by mouth
They generally last longer than oral medications—weeks to months—so they are administered less frequently
Powerful Medications to Treat IBD
Infusion Medications
Remicade®
Remicade infusion medication is used to treat a number of conditions in adults and pediatric patients, including moderate to severe Crohn’s disease, moderate to severe ulcerative colitis, moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and chronic severe (extensive and/or disabling) plaque psoriasis.
Click here for more information.
Renflexis®
RENFLEXIS® is a prescription infusion medication used to treat several conditions — including ulcerative colitis (UC) and Crohn’s disease in adults and pediatric patients. It can also treat rheumatoid arthritis (RA), psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis in adults.
Click here for more information.
Inflectra®
This drug is similar to Remicade and is prescribed to both adult and pediatric patients for the treatment of Crohn’s disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis. This medication helps manage immune cell levels and helps reduce overall inflammation in the body.
Click here for more information.
Injectafer®
Injectafer is a prescription iron replacement used to treat anemia for adults and pediatric patients one year and older. This intravenous medication is also used to treat iron deficiency in patients living with chronic kidney disease and who are not undergoing dialysis.
Click here for more information.
Omvoh™
Omvoh is FDA-approved to treat ulcerative colitis (UC) in adults with moderate to severe symptoms. UC is a type of inflammatory bowel disease (IBD). It causes inflammation that leads to ulcers in the large intestine, which includes the colon and rectum.
Click here for more information.
Actemra®
Actemra (tocilizumab) is a FDA approved biological medicine that is given by intravenous infusion or injection under the skin to treat specific patients with COVID-19, rheumatoid arthritis, giant cell arteritis, scleroderma, polyarticular or systemic juvenile idiopathic arthritis, and severe cytokine release syndrome.
Click here for more information.
Benlysta
BENLYSTA is a prescription medicine used to treat people aged 5 and older with active systemic lupus erythematosus (SLE or lupus) or with active lupus nephritis (lupus-related kidney inflammation) who are receiving other lupus medicines.
BENLYSTA is not for people with severe active central nervous system lupus.
Click here for more information.
Skyrizi®
We prescribe SKYRIZI to treat adults with moderate to severe plaque psoriasis active psoriatic arthritis and moderate to severe Crohn’s disease. The medication is an immune protein that helps to reduce inflammation that may lead to plaque on the skin.
Click here for more information.
Entyvio®
We prescribe Entyvio (vedolizumab) to treat adults with moderately to severely active ulcerative colitis and moderately to severely active Crohn’s disease. This medication works by preventing an excess of white blood cells from entering the GI tract, which helps control inflammation in the body.
Click here for more information.
Stelara®
STELARA (ustekinumab) is an intravenous infusion prescription we prescribe to treat adults and children six years and older living with moderate to severe plaque psoriasis and adults living with psoriatic arthritis, moderate to severe Crohn’s disease and Ulcerative colitis. The intravenous drug targets gastrointestinal inflammation throughout the body.
Click here for more information.
Tysabri®
We use Tysabri (natalizumab) to treat Crohn’s disease as well as relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. This drug is considered an immunosuppressant that works by stopping immune system cells from causing inflammation in the body.
Click here for more information.
Krystexxa®
KRYSTEXXA® (pegloticase) is indicated for the treatment of chronic gout in adult patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.
Click here for more information.
Orencia®
ORENCIA® (abatacept) is a prescription medicine that reduces signs and symptoms in adults with moderate to severe RA, including those who have not been helped enough by other medicines for RA. ORENCIA may prevent further damage to your bones and joints and may help your ability to perform daily activities. In adults, ORENCIA may be used alone or with other RA treatments other than Janus kinase (JAK) inhibitors or biologic disease-modifying antirheumatic drugs (bDMARDs), such as tumor necrosis factor (TNF) antagonists.
Click here for more information.
Reclast®
Reclast (sometimes called zoledronate) is a bisphosphonate medicine that alters bone formation and breakdown in the body. This can slow bone loss and may help prevent bone fractures.
Reclast is used to treat or prevent osteoporosis caused by menopause, or steroid use. This medicine also increases bone mass in men with osteoporosis. Reclast is for use when you have a high risk of bone fracture.
Click here for more information.
Simponi Aria®
SIMPONI ARIA® (golimumab) is a prescription medicine. SIMPONI ARIA® can lower your ability to fight infections. There are reports of serious infections caused by bacteria, fungi, or viruses that have spread throughout the body, including tuberculosis (TB) and histoplasmosis. Some of these infections have been fatal. Your doctor will test you for TB before starting SIMPONI ARIA® and will closely monitor you for signs of TB during treatment. Tell your doctor if you have been in close contact with people with TB. Tell your doctor if you have been in a region (such as the Ohio and Mississippi River Valleys and the Southwest) where certain fungal infections like histoplasmosis or coccidioidomycosis are common.
Click here for more information.
Injectable Medications
Want support for injected medications?
Have you been prescribed a self injection medication such as Humira, Cimzia, Stelara, or Skyrizi? Are you feeling overwhelmed by the self-administration process? We can:
Receive and securely store medication deliveries
Administer the injection by experienced nurses so you do not have to give yourself the injection, or you may book a one-on-one teaching session
Cimzia®
CIZMIA (certolizumab pegol) is a Tumor Necrosis Factor (TNF) blocker that works to decrease the signs and symptoms of moderate to severe Crohn’s disease, moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, moderate to severe plaque psoriasis and non-radiographic axial spondyloarthritis. This injectable medication may be prescribed for patients who have not found relief with other treatments.
Click here for more information.
Humira®
We prescribe the injectable HUMIRA (adalimumab) to treat pain and swelling associated with inflammatory bowel disease (IBD) certain types of arthritis, including rheumatoid, psoriatic, juvenile idiopathic and ankylosing spondylitis. HUMIRA also treats skin conditions including plaque-type psoriasis and hidradenitis suppurativa. HUMIRA is a tumor necrosis factor (TNF) that reduces inflammation in the body.
Click here for more information.
Skyrizi®
We prescribe SKYRIZI to treat adults with moderate to severe plaque psoriasis, active psoriatic arthritis and moderate to severe Crohn’s disease. The medication is an immune protein that helps to reduce inflammation that may lead to plaque on the skin.
Click here for more information.
Stelara®
STELARA (ustekinumab) is an intravenous infusion prescription we prescribe to treat adults and children six years and older living with moderate to severe plaque psoriasis and adults living with psoriatic arthritis, moderate to severe Crohn’s disease and Ulcerative colitis. The intravenous drug targets gastrointestinal inflammation throughout the body.
Click here for more information.
Get In Contact
If you are a patient or a physician that has questions about our infusion therapy services or needs to get in touch with our staff, contact us today.